![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Analysis of Efficacy by Baseline Viral Load: Phase 3 Study Comparing Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (Quad) versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF in Treatment Naïve HIV-1 Infected Subjects: Week 48 Results
|
|
|
Reported by jules Levin
19th Intl AIDS Conference July 22-27 2012 Wash DC USA
E DeJesus1, JK Rockstroh2, K Henry3, J-M Molina4, J Gathe5,
S Ramanathan6, X Wei6, J Szwarcberg6, M Rhee6, A Cheng6
1Orlando Immunology Center, Orlando, FL, US; 2Department of Medicine I, University of Bonn, Bonn, Germany; 3Hennepin County Medical Center, Minneapolis, MN, US; 4Saint Louis Hospital, Paris, France; 5Therapeutic Concepts P.A., Houston, TX, US; 6Gilead Sciences, Foster City, CA, US
![IAC1.gif](../images/072512/072512-3/IAC1.gif)
![IAC2.gif](../images/072512/072512-3/IAC2.gif)
![IAC3.gif](../images/072512/072512-3/IAC3.gif)
![IAC4.gif](../images/072512/072512-3/IAC4.gif)
![IAC5.gif](../images/072512/072512-3/IAC5.gif)
![IAC6.gif](../images/072512/072512-3/IAC6.gif)
![IAC7.gif](../images/072512/072512-3/IAC7.gif)
![IAC8.gif](../images/072512/072512-3/IAC8.gif)
![IAC9.gif](../images/072512/072512-3/IAC9.gif)
![IAC10.gif](../images/072512/072512-3/IAC10.gif)
![IAC11.gif](../images/072512/072512-3/IAC11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|